Concepedia

Chemotherapy treatment is associated with altered PD-L1 expression in lung cancer patients

Lívia Rojkó, Lilla Reiniger, Vanda Téglási, Katalin Fábián, Orsolya Pipek, Attila Vágvölgyi, László Agócs, János Fillinger, Zita Kajdácsi, Balázs Döme,

Journal of Cancer Research and Clinical Oncology · 2018 · 99 citations · 15 references

DOIFull text

Open access

Concepts

References

15

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

Martin Reck, Delvys Rodríguez‐Abreu, Andrew Robinson et al. · New England Journal of Medicine · 2016 · 10.1K citations · Full text

, , +17

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

Roberto Salgado, Carsten Denkert, Sandra Demaria et al. · Annals of Oncology · 2014 · 3.1K citations · Full text

, , +16

The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor Characteristics

Ting‐Yuan David Cheng, Susanna Cramb, Peter D. Baade et al. · Journal of Thoracic Oncology · 2016 · 616 citations · Full text

, , +17

Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer

Peng Jin, Junzo Hamanishi, Noriomi Matsumura et al. · Cancer Research · 2015 · 522 citations

, , +17

Chemopreventive agents induce programmed death-1-ligand 1 (PD-L1) surface expression in breast cancer cells and promote PD-L1-mediated T cell apoptosis

Ping Zhang, Dongming Su, Mei Liang et al. · Molecular Immunology · 2007 · 264 citations

, , +17